About Us

Indian Council of Medical Research (ICMR), New Delhi is the apex body in India for the formulation, coordination and promotion of biomedical research. ICMR is one of the oldest medical research bodies in the world. ICMR has always attempted to address itself to the growing demands of scientific advances in biomedical research and to the need of finding practical solutions to the health problems of the country.

ICMR has been receiving several novel claims like drug molecules, AYUSH formulations, disinfectants, devices, tools and technologies, to facilitate evaluation and validation for COVID-19. Subsequently, ICMR has collaborated with other Science Departments like Department of Biotechnology (DBT), Council of Scientific and Industrial Research (CSIR), Department of Science and Technology (DST) and other agencies to address these novel claims. ICMR is currently collaborating with 15 National Institutes from three Ministries.

iNoveCOP is a web-based portal developed by ICMR, to guide applicants related to various claims related to COVID-19. Applicants may submit their claim through this portal for guidance and/(or) evaluation of their innovation from independent agencies.

Steps on how to Fill your Claim Manual



Note:

  • ICMR is not the regulatory body for approval of drugs, devices, disinfectants or other related products for human use. Those requiring regulatory approval or grant of permission or license must register with the Drugs Controller General of India (DCGI)/ Central Drugs Standard Control Organization (CDSCO), which is the regulatory body for approval or certification or license of drugs, medical products, disinfectants, sanitizers and devices for human use.
  • “As per Section 3(aaa) of Drugs and Cosmetics Act, 1940 “Cosmetic” means “any article intended to be rubbed, poured, sprinkled or sprayed on, or introduced into, or otherwise applied to, the human body or any part thereof for cleansing, beautifying, promoting attractiveness, or altering the appearance and includes any article intended for use as a component of cosmetic.”
  • Under the provisions of Drugs and Cosmetics Act, 1940 and Rules made thereunder, the manufacture of cosmetics in India is regulated under a system of inspection and licensing by the State Licensing Authorities appointed by the respective State Governments while the import of cosmetics is regulated under a system of registration by the Licensing Authority appointed by the Central Government.“
  • A National Task Force to deal with issues pertaining to the Ayurveda system of Medicine particularly in relation to COVID-19, is being established by the Ministry of AYUSH, Government of India. Hence, applicants of products or proposals related to Ayurveda, Unani, Siddha, Homeopathy and Yoga are requested to contact the Ministry of AYUSH in relation to any sort of assessment of formulation of guideline for prevention or treatment related issues under the subject of AYUSH, Government of India.